Viatris Stock: Is VTRS Outperforming the Health Care Sector? [Yahoo! Finance]
Viatris Inc. (VTRS)
Company Research
Source: Yahoo! Finance
It operates at scale across 120+ countries, focusing on expanding access to affordable medicines worldwide Companies worth $10 billion or more are typically classified as “large-cap stocks,” and Viatris fits the label perfectly, with its market cap exceeding this threshold, underscoring its size, influence, and dominance within the specialty & generic drug manufacturers industry. Its competitive strength lies in its global scale, diversified portfolio, and cost-efficient manufacturing model, enabling it to deliver affordable medicines across both developed and emerging markets. More News from Barchart Micron Technology Hikes Its Dividend 30% Due to Surging FCF - MU Is Worth 34% More - What's the Best Play? As Trump Admin Warns on Airport Closures, Should You Sell Delta Airlines Stock? Iran War, Oil Volatility and Other Key Things to Watch This Week Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable tr
Show less
Read more
Impact Snapshot
Event Time:
VTRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTRS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTRS alerts
High impacting Viatris Inc. news events
Weekly update
A roundup of the hottest topics
VTRS
News
- Shreehas Tambe Appointed CEO & Managing Director of Biocon Limited, Effective April 1, 2026 [Yahoo! Finance]Yahoo! Finance
- Is WisdomTree U.S. MidCap Dividend ETF (DON) a Strong ETF Right Now? [Yahoo! Finance]Yahoo! Finance
- Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD) [Yahoo! Finance]Yahoo! Finance
- Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD)PR Newswire
- Will Viatris' 2030 Capital Return And Growth Blueprint Change Viatris' (VTRS) Narrative [Yahoo! Finance]Yahoo! Finance
VTRS
Earnings
- 2/26/26 - Beat
VTRS
Sec Filings
- 3/27/26 - Form SCHEDULE
- 3/24/26 - Form 4
- 3/23/26 - Form 144
- VTRS's page on the SEC website